Volume Alert - MON 119.07 Monsanto Company $MON Hit a high

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - MON 119.07 Monsanto Company $MON Hit a high today of 119.49 Closing the day 10:30 at 119.07 +0.76 +0.64% With a day low of 117.79 and a total volume of 1,148,207.

MON Recent Posts: http://investorshangout.com/Monsanto-Company-MON-51848/

MON Monsanto Company Recent Headline News

Monsanto says ongoing EPS could "at least double" over five years
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 9:15AM CST

MON: 118.98 (+0.67)

Stock Market News for November 12, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 9:10AM CST
Benchmarks were little changed on Tuesday as investors hardly found any reason to place big bets
DHI: 23.96 (+0.01), MON: 118.98 (+0.67), NEM: 18.33 (-0.37), BZH: 18.48 (-0.77), CVC: 18.20 (+0.11), JNPR: 20.60 (+0.32), ZTS: 42.99 (-0.73), LEN: 45.32 (-1.07), LYB: 88.15 (-0.39), CF: 267.07 (+0.26), PHM: 20.72 (-0.25), DD: 70.16 (-0.65), TWC: 136.94 (+2.16), TOL: 33.45 (-0.27), DOW: 49.72 (+0.20), ECL: 112.74 (-0.05)

Global Herbicides (Type, Mode of action, Crop Type and Geography) Market 2013 - 2020
M2 - Wed Nov 12, 8:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/9jtwlz/global_herbicides) has announced the addition of the "Global Herbicides Market (Type, Mode of action, Crop Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020 " report to their offering. The global herbicide market is segmented on the basis of type, mode of selection, crop type and geography (country level). The type segment is further categorized into Glyphosate, Atrazine, Acetochlor, 2,4-D, Paraquat, Bio-Herbicide and Others. Glyphosate herbicide dominates the global market in terms of value and volume both. Bio-herbicide is emerging as potential future alternative to synthetic herbicides, although commercial production of bio herbicide is still very low. Based on the mode of selection, the global herbicide market is segmented into selective and non-selective herbicide. Demand for non-selective herbicide is growing in the market, replacing selective herbicide. By crop type, the global herbicide market is divided into Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables and Cotton. Herbicides are majorly used in cereals and grains. Geographically, the global herbicide market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America and Europe dominate the global market due to comparatively high price of herbicides with respect to other regions. Scope of the Report Type - Glyphosate - Atrazine - Acetochlor - 2,4-D - Paraquat - Bio-herbicide - Others Action - Selective - Non-selective Crop Type - Cereals and Grains - Oilseeds & Pulses - Fruits & Vegetables - Cotton Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL HERBICIDES MARKET, BY TYPE CHAPTER 5 GLOBAL HERBICIDES MARKET, BY MODE OF ACTION CHAPTER 6 GLOBAL HERBICIDES MARKET, BY CROP TYPE CHAPTER 7 GLOBAL HERBICIDES MARKET, BY APPLICATION CHAPTER 8 GLOBAL HERBICIDES MARKET, BY GEOGRAPHY CHAPTER 9 COMPANY PROFILES - Adama Agricultural Solutions Ltd - BASF - Bayer AG - Cheminova A/S - DOW Agriscience LLC - E.I Du Pont de Numerous - FMC Corporation - Monsanto Company - Nufarm Ltd - Syngenta AG For more information visit http://www.researchandmarkets.com/research/9j...herbicides
SYT: 63.55 (+0.42), MON: 118.98 (+0.67), ADAM: (), FMC: 56.64 (-0.18)

Monsanto Trades Below Fair Value And Offers Dividend Growth
Jonathan Weber - at Seeking Alpha - Wed Nov 12, 2:18AM CST

MON: 118.98 (+0.67)

Watch for Shares of Monsanto (MON) to Approach Resistance at $118.80
Comtex SmarTrend(R) - Tue Nov 11, 11:40AM CST
Shares of Monsanto (NYSE:MON) have bullishly opened above the pivot of $116.17 today and have reached the first resistance level of $117.85. Investors may be interested in a cross of the next upside pivot targets of $118.80 and $121.43.
MON: 118.98 (+0.67)

Voters Say "Heck No, Don't Label GMO!"
Rich Duprey, The Motley Fool - Motley Fool - Tue Nov 11, 11:30AM CST
Voters in two states rejected ballot initiatives last week that would have required foods containing genetically modified organisms to carry labels identifying the presence of such ingredients, handing big wins to food manufacturers like General...
SYT: 63.55 (+0.42), MON: 118.98 (+0.67), DD: 70.16 (-0.65), KRFT: 57.44 (-0.44), GIS: 50.84 (-0.13), DOW: 49.72 (+0.20), PEP: 97.17 (+0.47)

Basic Materials Stocks On The Rise With Help From 3 Stocks
at The Street - Tue Nov 11, 11:05AM CST
TheStreet highlights 3 stocks pushing the basic materials sector higher today.
MON: 118.98 (+0.67), CF: 267.07 (+0.26), GG: 19.45 (-0.14)

Watch for Monsanto to Potentially Pullback After Gaining 2.14% Yesterday
Comtex SmarTrend(R) - Mon Nov 10, 3:42PM CST
Monsanto (NYSE:MON) traded in a range yesterday that spanned from a low of $114.50 to a high of $117.13. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $115.43 on volume of 5.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MON: 118.98 (+0.67)

Monsanto Rises 2.14% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Nov 10, 3:42PM CST
Monsanto (NYSE:MON) traded in a range yesterday that spanned from a low of $114.50 to a high of $117.13. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $115.43 on volume of 5.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MON: 118.98 (+0.67)

Will Evogene (EVGN) Report Wider-than-Expected Q3 Loss? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 4:10PM CST
Evogene (EVGN) is scheduled to report third-quarter 2014 results before the opening bell on Nov 10.
MNK: 92.93 (-0.78), EVGN: 9.99 (-0.25), MON: 118.98 (+0.67), DNDN: 0.16 (+0.01)

Investments, Quarterly Results, and Upcoming Conferences - Research Reports on ExxonMobil, Chevron, Halliburton, Schlumberger and Monsanto
PR Newswire - Fri Nov 07, 8:30AM CST
Today, Analysts Review released its research reports regarding Exxon Mobil Corporation (NYSE: XOM), Chevron Corporation (NYSE: CVX), Halliburton Company (NYSE: HAL), Schlumberger Limited (NYSE: SLB) and Monsanto Company (NYSE: MON). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7794-100free.
MON: 118.98 (+0.67), HAL: 53.59 (-0.13), XOM: 95.53 (-0.88), CVX: 118.01 (-0.43), SLB: 98.16 (-0.20)

What A Strong U.S. Dollar Means For Investors, Consumers, Companies, And The Economy
Michael Maggi, CFA - at Seeking Alpha - Fri Nov 07, 7:18AM CST

KO: 42.78 (+0.27), MON: 118.98 (+0.67), IBM: 162.30 (-1.00), MCD: 95.18 (+0.04), XOM: 95.53 (-0.88), INTC: 33.34 (+0.03), CVX: 118.01 (-0.43), DOW: 49.72 (+0.20), SLB: 98.16 (-0.20)

Business Highlights
By The Associated Press - AP - Thu Nov 06, 4:56PM CST
___
MON: 118.98 (+0.67), LNKD: 231.23 (+0.23)


Despite losses, GMO label backers aren't quitting
By GOSIA WOZNIACKA - AP - Thu Nov 06, 11:04AM CST
PORTLAND, Ore. (AP) — In the end, not even Oregon's backyard chicken owners and vegan foodies had enough money and clout to persuade voters to pass a ballot measure that would have required labeling of genetically modified foods.
MON: 118.98 (+0.67)

Monsanto - Desirable Dividend Fundamentals, But Pricey
Dividends4Life - Seeking Alpha - Thu Nov 06, 1:13AM CST
Linked here is a detailed quantitative analysis of Monsanto Co. (NYSE: MON ). Below are some highlights from the above linked analysis: Company Description: Monsanto Co. is a global provider of agricultural products and integrated solutions for...
MON: 118.98 (+0.67)

5 Things to Know About Massachusetts Casinos
By PHILIP MARCELO - AP - Wed Nov 05, 11:10AM CST
BOSTON (AP) — The march toward Las Vegas-style gambling in the Bay State begins in earnest now that voters have resoundingly defeated a ballot question to repeal the state's 2011 casino law. Anti-casino advocates have left the door open for another repeal effort someday, but the following is a closer look at what's on the horizon for Massachusetts' nascent casino industry:
MON: 118.98 (+0.67)

20 Stocks That Could Beat the Market in November: Priceline, U.S. Steel Lead Way
at The Street - Wed Nov 05, 10:24AM CST
Which stocks have historically done the best in November, typically one of the best months to invest?
BIIB: 320.73 (-3.86), MNST: 107.64 (+0.63), ATI: 32.37 (+0.28), MON: 118.98 (+0.67), GMCR: 153.02 (-1.67), VMC: 65.67 (+0.32), EMR: 64.18 (-0.38), WDC: 97.61 (+0.66), VRSN: 60.13 (+0.20), URBN: 31.86 (+1.05), FSLR: 49.51 (-1.48), DE: 88.23 (-0.22), EXPE: 86.92 (+0.46), FLR: 65.84 (-0.06), FLS: 67.21 (+0.37), X: 35.20 (+0.14), ROK: 113.50 (+0.64), REGN: 400.15 (+1.79), MA: 84.45 (-0.14)

Maui votes to ban genetically modified organisms
By AUDREY McAVOY - AP - Wed Nov 05, 5:01AM CST
HONOLULU (AP) — Maui County voters opted Tuesday to temporarily ban the cultivation of genetically engineered crops after a hard-fought campaign featuring $8 million in advertising from some of the world's largest corn-seed producers.
MON: 118.98 (+0.67), DOW: 49.72 (+0.20)

Mosanto's Solid Fundamentals And High Growth Should Entice Investors
Vuru - Seeking Alpha - Fri Oct 31, 5:51AM CDT
Monsanto Company (NYSE: MON ) , together with its subsidiaries, provides agricultural products for farmers in the US and internationally. The company operates in two segments, seeds and genomics, and agricultural productivity. The seeds and genomics...
MON: 118.98 (+0.67)

Are XLB And Materials Overpriced?
Fred Piard - at Seeking Alpha - Thu Oct 30, 1:46PM CDT

XLB: 49.04 (+0.03), LYB: 88.14 (-0.40), MON: 118.98 (+0.67), DD: 70.16 (-0.65), PX: 126.07 (-0.63), PPG: 203.94 (-1.32), DOW: 49.72 (+0.20), APD: 134.76 (-0.16), ECL: 112.74 (-0.05)

Monsanto Company (MON) Stock Research Links

MON Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 8

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 11

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 11

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 7

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 12

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 5

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

A Closer Look at Marvell Tech's Upcoming Earnings Release

Updated Category News Views 184

Marvell Tech's Expected Earnings Release Marvell Tech (NASDAQ: MRVL) is set to announce its latest quarterly earnings in December. As investors await this critical financial moment, a brief review of what to expect can shed light on potential impacts and opportunities. Analysts' Earnings Projections Analysts forecast that Marvell Tech will achieve an earnings per share...

Continue Reading
Banijay Group's Recent Share Transactions Update and Insights

Updated Category News Views 222

Recent Share Transactions Overview Banijay Group N.V. (ISIN: NL0015000X07, Bloomberg: BNJ NA, Reuters: BNJ.AS) has reported on its recent share transactions, showcasing the buying and selling activities from the period of September 22 to September 26. Understanding Share Transactions During this timeframe, a mix of buying and selling occurred within the company’s...

Continue Reading
Strategic Growth for Voyageur Mineral Explorers via New Offering

Updated Category News Views 143

Voyageur Mineral Explorers Corp. Secures Massive Funding Voyageur Mineral Explorers Corp. (CSE: VOY) has recently made headlines by completing a significant brokered offering, raising $37.5 million. This financial boost comes at a crucial time for the Company as it seeks to expand its operations and investments in the mineral exploration sector. The offering was executed...

Continue Reading
Applied Materials Faces Challenges Amid Weak Outlook and Stocks

Updated Category News Views 114

Applied Materials Inc. Stock Performance Applied Materials Inc. (NASDAQ: AMAT) recently experienced a noticeable decline in its stock value as the company shared its financial results. After the market closure, the organization revealed its third-quarter earnings, leading to significant concern among investors. The stock's value tumbled, reflecting the market's reaction...

Continue Reading
VFC Class Action Demands Attention: Key Details for Investors

Updated Category News Views 192

Understanding the VFC Class Action Lawsuit Investors in V.F. Corporation, commonly known as VFC, should pay close attention to a pending class action lawsuit that could have significant implications. The law firm Faruqi & Faruqi, a reputable name in securities litigation, has stepped forward to represent affected investors. They are drawing attention to a critical...

Continue Reading